Chandler Capital

Chandler Capital

Expertise: Technology, Pharmaceutical, Energy, GARP

Chandler Capital is the work of Ian Hartana and Vayun Chugh.

Ian Hartana is a self-taught investor whose work has been featured on Seeking Alpha under the organization AlmaStreet Capital. Being on the student advisory board of the Young Investors Society, he is a long-time advocate for the advancement of financial literacy and has competed on the international level in multiple competitions. In his free time, he enjoys exploring the intersection between behavioral science and economics through writing on the platform Medium and is currently working as an intern at a small venture capital firm.

Vayun Chugh is also a self-taught investor and is both an editor and writer for AlmaStreet Capital. He is the president of his school’s finance club alongside Ian Hartana, and has also competed in multiple international competitions. Through his ongoing research in the medical field, Vayun has developed a deep understanding of the pharmaceutical industry and knows the characteristics of an undervalued company.

Ian and Vayun’s expertise lies in finding value in undervalued companies in the tech, pharmaceutical, and energy sectors which have the potential for growth at a reasonable price. They have a long-term investment horizon and consider ESG as an increasingly important factor in their research process.

Recent Articles

Wall Street’s Favorite Fintech Stocks? 3 Names That Could Make You Filthy Rich

As we move into a future where everything can be done from our smartphones, here are 3 fintech stocks that are changing the world of finance. 

The 3 Most Undervalued Large-Cap Stocks to Buy in March 2024

Finding undervalued stocks while others are chasing higher multiples is a great way to pivot from crowded trades. Here are three undervalued large-cap stocks that can perform well in March. 

The 3 Most Undervalued Renewable Energy Stocks to Buy in March 2024

With interest rates having peaked, here are three undervalued renewable energy stocks bound to make a strong, profitable recovery.

The 3 Most Undervalued Biotech Stocks to Buy in March 2024

 These 3 undervalued biotech stocks have been left behind so far but things could begin to turn around as we head into March. 

The Top 3 Real Estate Stocks to Buy in March 2024

With the potential for the real estate market to bounce back, here are our picks for the top 3 real estate stocks to buy in March 2024.